Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51K Hold
40
﹤0.01% 506
2025
Q4
$2.65K Hold
40
﹤0.01% 498
2025
Q3
$2.69K Hold
40
﹤0.01% 492
2025
Q2
$3.49K Hold
40
﹤0.01% 424
2025
Q1
$2.73K Hold
40
﹤0.01% 446
2024
Q4
$3.11K Hold
40
﹤0.01% 445
2024
Q3
$2.68K Hold
40
﹤0.01% 470
2024
Q2
$4.54K Hold
40
﹤0.01% 363
2024
Q1
$5.55K Hold
40
﹤0.01% 329
2023
Q4
$4.96K Hold
40
﹤0.01% 298
2023
Q3
$3.73K Hold
40
﹤0.01% 329
2023
Q2
$5.14K Hold
40
﹤0.01% 283
2023
Q1
$4.65K Hold
40
﹤0.01% 287
2022
Q4
$4.53K Buy
+40
New +$4.39K ﹤0.01% 328
2021
Q4
Sell
-160
Closed -$3K 196
2021
Q3
$3K Buy
+160
New +$20.2K ﹤0.01% 357

Other funds holding DXCM

Red Tortoise LLC's DXCM Position: Q1 2026 in Review

Red Tortoise LLC held its DexCom (DXCM) position steady in Q1 2026 at 40 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Red Tortoise LLC first reported a position in DXCM in Q3 2021 and has held it in 15 quarters since. The position peaked at $5.55K in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Red Tortoise LLC held 40 shares of DexCom worth $2.51K as of Q1 2026.
  • Red Tortoise LLC left its DexCom share count unchanged in Q1 2026.
  • DexCom made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #506 holding.
  • Red Tortoise LLC first reported a position in DexCom in Q3 2021 and has held it in 15 quarters since.
  • Red Tortoise LLC's DexCom position peaked at $5.55K in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.